Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Avadel Pharmaceuticals

    NASDAQ: AVDL · Real-Time Price · USD
    9.74
    0.30 (3.18%)
    At close: Jun 06, 2025, 3:59 PM
    9.72
    -0.21%
    After-hours: Jun 06, 2025, 04:04 PM EDT

    Avadel Pharmaceuticals Statistics

    Share Statistics

    Avadel Pharmaceuticals has 96.74M shares outstanding. The number of shares has increased by 0.53% in one year.

    Shares Outstanding

    n/a
    		 96.74M

    Shares Change (YoY)

    n/a
    		 0.53%

    Shares Change (QoQ)

    n/a
    		 0.28%

    Owned by Institutions (%)

    n/a
    		 82.38%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 7

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 10.76M, so 11.12% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.76M

    Short % of Shares Out

    n/a
    		 11.12%

    Short % of Float

    n/a
    		 13.08%

    Short Ratio (days to cover)

    n/a
    		 6.58

    Valuation Ratios

    The PE ratio is -20.48 and the forward PE ratio is 12.25. Avadel Pharmaceuticals's PEG ratio is 0.27.

    PE Ratio

    n/a
    		 -20.48

    Forward PE

    n/a
    		 12.25

    PS Ratio

    n/a
    		 5.91

    Forward PS

    n/a
    		 1.9

    PB Ratio

    n/a
    		 13.54

    P/FCF Ratio

    n/a
    		 -21.32

    PEG Ratio

    n/a
    		 0.27
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Avadel Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 2.75

    Quick Ratio

    n/a
    		 2.33

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 -3.91

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $899,558.51

    Profits Per Employee

    n/a
    		 $-259,744.68

    Employee Count

    n/a
    		 188

    Asset Turnover

    n/a
    		 1.03

    Inventory Turnover

    n/a
    		 0.75

    Taxes

    Income Tax

    n/a
    		 -247K

    Effective Tax Rate

    n/a
    		 0.5%

    Stock Price Statistics

    The stock price has increased by -35.62% in the last 52 weeks. The beta is 1.45, so Avadel Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.45

    52-Week Price Change

    n/a
    		 -35.62%

    50-Day Moving Average

    n/a
    		 8.53

    200-Day Moving Average

    n/a
    		 10.49

    Relative Strength Index (RSI)

    n/a
    		 62.08

    Average Volume (20 Days)

    n/a
    		 1,106,173

    Income Statement

    In the last 12 months, Avadel Pharmaceuticals had revenue of 169.12M and earned -48.83M in profits. Earnings per share was -0.51.

    Revenue

    n/a
    		 169.12M

    Gross Profit

    n/a
    		 153.84M

    Operating Income

    n/a
    		 -42.4M

    Net Income

    n/a
    		 -48.83M

    EBITDA

    n/a
    		 -35.57M

    EBIT

    n/a
    		 -38.25M

    Earnings Per Share (EPS)

    n/a
    		 -0.51
    Full Income Statement

    Balance Sheet

    The company has 51.37M in cash and 1.7M in debt, giving a net cash position of 49.67M.

    Cash & Cash Equivalents

    n/a
    		 51.37M

    Total Debt

    n/a
    		 1.7M

    Net Cash

    n/a
    		 49.67M

    Retained Earnings

    n/a
    		 -794.33M

    Total Assets

    n/a
    		 167.95M

    Working Capital

    n/a
    		 88.33M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -46.91M and capital expenditures 0, giving a free cash flow of -46.91M.

    Operating Cash Flow

    n/a
    		 -46.91M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -46.91M

    FCF Per Share

    n/a
    		 -0.49
    Full Cash Flow Statement

    Margins

    Gross margin is 90.97%, with operating and profit margins of -25.07% and -28.87%.

    Gross Margin

    n/a
    		 90.97%

    Operating Margin

    n/a
    		 -25.07%

    Pretax Margin

    n/a
    		 -29.02%

    Profit Margin

    n/a
    		 -28.87%

    EBITDA Margin

    n/a
    		 -21.03%

    EBIT Margin

    n/a
    		 -25.07%

    FCF Margin

    n/a
    		 -27.74%

    Dividends & Yields

    AVDL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AVDL is $16.5, which is 69.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $16.5

    Price Target Difference

    n/a
    		 69.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.4

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist